VBY-129

N/A

Report date: 2022/01/14 13:23:58

NME

Base Information

Drug NameVBY-129

Drug Alias NameVBY-129

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionCathepsin S inhibitors

TargetsCathepsin S

Therapy Area/IndicationsNeuralgiaCrohn Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesVirobay Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesVirobay Inc

Active IndicationsN/A

Inactive IndicationsNeuralgiaCrohn Disease

ATC CodeN/A